MENVEO VACCINE, SDV 10-5MG/0.5ML (5/CT)

 RESTRICTED - NOT ON FORMULARY

Menveo® Meningitis Vaccine Meningococcal (Groups A, C, Y, and W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine, Preservative Free 10 mcg – 5 mcg / 0.5 mL Injection Single Dose Vial 0.5 mL

This product is currently out of stock and unavailable.

Item No. 1064517 Categories ,

MENVEO is a vaccine indicated for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135. MENVEO is approved for use in persons 2 months through 55 years of age
MENVEO is supplied in two vials that must be combined prior to administration: reconstitute the MenA lyophilized conjugate vaccine component with the MenCYW-135 liquid conjugate vaccine component immediately before administration

Product Specification Sheet